Increasing aqueous solubility of curcumin for improving bioavailability

Trends in Pharmacological Sciences

Volumn 30, Issue 7, 2009, Pages 334-335

  Kurien, Biji T ^a   Scofield, R Hal ^a,b,c  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CURCUMA LONGA EXTRACT; CURCUMIN;

ADVANCED CANCER; AQUEOUS SOLUTION; CANCER PATIENT; COLORECTAL CANCER; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG FECES LEVEL; DRUG METABOLISM; DRUG SOLUBILITY; DRUG URINE LEVEL; HUMAN; LETTER; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN MODIFICATION;

ANIMALS; BIOLOGICAL AVAILABILITY; CURCUMIN; HUMANS; SOLUBILITY; TISSUE DISTRIBUTION; WATER;

EID: 67649414398     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2009.04.005     Document Type: Letter

References (10)

1. Aggarwal B.B., et al. Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol. Sci. 30 (2009) 85-94
2. Sharma R.A., et al. Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin. Cancer Res. 7 (2001) 1894-1900
3. Cheng A.L., et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 21 (2001) 2895-2900
4. Lao C.D., et al. Dose escalation of a curcuminoid formulation. BMC Complement. Altern. Med. 6 (2006) 10-13
5. Dhillon N., et al. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin. Cancer Res. 14 (2008) 4491-4499
6. Kurien B.T., et al. Improving the solubility and pharmacological efficacy of curcumin by heat treatment. Assay Drug Dev. Technol. 5 (2007) 567-576
7. Kurien B.T., et al. Increasing the solubility of the nutraceutical curcumin by heat and inhibition of oxidative modification. Mol. Nutr. Food Res. 53 (2009) 308
8. Kurien B.T., et al. In vitro modification of solid phase multiple antigenic peptides/autoantigens with 4-hydroxy-2-nonenal (HNE) provide ideal substrates for detection of anti-HNE antibodies and peptide antioxidants. J. Immunol. Methods 303 (2005) 66-75
9. Kurien B.T., et al. Curcumin/turmeric solubilized in sodium hydroxide inhibits HNE protein modification-an in vitro study. J. Ethnopharmacol. 110 (2007) 368-373
10. Kurien B.T., et al. Heat-solubilized curcumin should be considered in clinical trials for increasing bioavailability. Clin. Cancer Res. 15 (2009) 747